The URL can be used to link to this page

Home My WebLink Aboutresearch on COVID-19 published last week in the New England Journal of Medicine IPM.Note research on COVID-19 published last week in the New England Journal of Medicine Deborah Lovejoy Alesa Anderson Deborah Lovejoy SMTP alesaanderson@gmail.com research on COVID-19 published last week in the New England Journal of Medicine EX /O=REXBURGCITYMAIL/OU=FIRST ADMINISTRATIVE GROUP/CN=RECIPIENTS/CN=DEBORAHL EX /O=REXBURGCITYMAIL/OU=FIRST ADMINISTRATIVE GROUP/CN=RECIPIENTS/CN=DEBORAHL Received: from CoR-EntMExSvr01.ci.rexburg.id.us (10.10.0.111) by CoR-EntMExSvr01.ci.rexburg.id.us (10.10.0.111) with Microsoft SMTP Server (TLS) id 15.0.847.32 via Mailbox Transport; Wed, 18 Nov 2020 11:53:47 -0700 Received: from CoR-EntMExSvr01.ci.rexburg.id.us (10.10.0.111) by CoR-EntMExSvr01.ci.rexburg.id.us (10.10.0.111) with Microsoft SMTP Server (TLS) id 15.0.847.32; Wed, 18 Nov 2020 11:53:46 -0700 Received: from mail.rexburg.org (10.10.0.3) by CoR-EntMExSvr01.ci.rexburg.id.us (10.10.0.111) with Microsoft SMTP Server id 15.0.847.32 via Frontend Transport; Wed, 18 Nov 2020 11:53:46 -0700 X-ASG-Debug-ID: 1605725595-15095536b2afea30001-jsWnyn Received: from mail-pj1-f53.google.com (mail-pj1-f53.google.com [209.85.216.53]) by mail.rexburg.org with ESMTP id xO3jt2Ejb2yylfmP for <customerservices@rexburg.org>; Wed, 18 Nov 2020 11:53:16 -0700 (MST) X-Barracuda-Envelope-From: alesaanderson@gmail.com X-Barracuda-Effective-Source-IP: mail-pj1-f53.google.com[209.85.216.53] X-Barracuda-Apparent-Source-IP: 209.85.216.53 Received: by mail-pj1-f53.google.com with SMTP id oc3so1568790pjb.4 for <customerservices@rexburg.org>; Wed, 18 Nov 2020 10:53:16 -0800 (PST) DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=gmail.com; s=20161025; h=from:to:subject:date:message-id:mime-version:thread-index :content-language; bh=URJBbtNJa9IUG8/I0WrbDxaYSGWL5v8atNXxM63lu9Q=; b=An/GNMHYxU1wghorrukAZ+ytcPL7kWLLczCk70VJkPkgtE0+ui12oB3cSLHnnp90Gb XgsQF6+eO8XgCMEZple1bq7Axz08ovHHyQ5DnMlU4E0NkuR2/So7XAi4oXE32IrwQHun VtuiiGC6qhM1T3D98lPKHqAB1+HtnMwbrPFawY2Xz6VWOS05DPi0W1E2ZCl7jUmH/Vqt WNINmCaXxkInec4gybdttSEKKsDSkfzsTycTDW4FtXnzvW545w4p8jgyamaNSJ5Jmfpq gw7QOA0Ha53+KGn7G5pReFCn+g+gi8i7s/6GCoMADofTKFZuywyY0LYGn5Bd9Zb19Ujw +Alw== X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20161025; h=x-gm-message-state:from:to:subject:date:message-id:mime-version :thread-index:content-language; bh=URJBbtNJa9IUG8/I0WrbDxaYSGWL5v8atNXxM63lu9Q=; b=MhddAN+kABmzc1LXPRG0Q/86K95ICunUuR1BQKPSYzWMOwh/bc2x+/8aKtdiFq2qCr 2Hl+nVYj3hustR2HGOS3VC52UoV2BHC0FOlDxeb/pDLMya4ERCV/fg/EP1DatVjGweW0 7ibK9pg+6VdG+6bhSblMG+8phNJDvBOOd7cHXVSY4byTpB/F7cPe6rcB5Cdcwvpg9xue qNpW6DYsisLkgnUNW1lS6TGHabUqhzrwsiAL87+wy6jSHIj7KHgMbFIXpEF/2PHVgRJj bSyN1ikva879km4dr2iOAOZkksaDqb0gPHGo5mLB+Kt26tg4cBBpM93k6aaLWWvK/TnK EOXg== X-Gm-Message-State: AOAM531BEMGFO+9lhz5X0lWNrnDFBW536FZEvAxTUvSso8O0m+gXMV5R LOIBc0GVvSirycJzNqVsfO1CHeXsi/0= X-Google-Smtp-Source: ABdhPJwH1R2cz8tg/SmojlddAngVZ4XCXK6Xm7NGE04dLpODLGdhk/r9okD/IlWBB/Dim5MHzD7gcA== X-Received: by 2002:aa7:9ece:0:b029:18c:4931:a4e6 with SMTP id r14-20020aa79ece0000b029018c4931a4e6mr5787878pfq.56.1605723687348; Wed, 18 Nov 2020 10:21:27 -0800 (PST) Received: from Userpc ([2001:5b0:4fc2:ae88:3007:c849:456e:a2d5]) by smtp.gmail.com with ESMTPSA id 38sm22746385pgx.43.2020.11.18.10.21.23 for <customerservices@rexburg.org> (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128); Wed, 18 Nov 2020 10:21:26 -0800 (PST) From: Alesa Anderson <alesaanderson@gmail.com> To: <customerservices@rexburg.org> Subject: research on COVID-19 published last week in the New England Journal of Medicine Date: Wed, 18 Nov 2020 11:21:16 -0700 X-ASG-Orig-Subj: research on COVID-19 published last week in the New England Journal of Medicine Message-ID: <017701d6bdd7$9f9a0da0$dece28e0$@gmail.com> MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0178_01D6BD9C.F33DA6A0" X-Mailer: Microsoft Outlook 15.0 Thread-Index: Ada900N8/G2yGOOaQruQvF6xoGiUDA== Content-Language: en-us X-Barracuda-Connect: mail-pj1-f53.google.com[209.85.216.53] X-Barracuda-Start-Time: 1605725596 X-Barracuda-URL: https://10.10.0.3:443/cgi-mod/mark.cgi X-Virus-Scanned: by bsmtpd at rexburg.org X-Barracuda-Scan-Msg-Size: 10363 X-Barracuda-BRTS-Status: 1 X-Barracuda-Spam-Score: 0.00 X-Barracuda-Spam-Status: No, SCORE=0.00 using global scores of TAG_LEVEL=3.5 QUARANTINE_LEVEL=1000.0 KILL_LEVEL=4.0 tests=HTML_MESSAGE X-Barracuda-Spam-Report: Code version 3.2, rules version 3.2.3.85962 Rule breakdown below pts rule name description ---- ---------------------- -------------------------------------------------- 0.00 HTML_MESSAGE BODY: HTML included in message Return-Path: alesaanderson@gmail.com X-MS-Exchange-Organization-Network-Message-Id: 4735a336-a148-44f4-0de2-08d88bf34794 X-MS-Exchange-Organization-AVStamp-Enterprise: 1.0 X-Auto-Response-Suppress: DR, OOF, AutoReply X-MS-Exchange-Organization-AuthSource: CoR-EntMExSvr01.ci.rexburg.id.us X-MS-Exchange-Organization-AuthAs: Anonymous Alesa Anderson SMTP alesaanderson@gmail.com Customer Services Inbox research on COVID-19 published last week in the New England Journal of Medicine Dear Council Members, Due to the meeting tonight regarding the mandating of masks, I have attached the following article from THE BLEEDING EDGE Newsletter. Below are the results of some very interesting research on COVID-19 that was published last week in the New England Journal of Medicine. The purpose of the study was to determine the efficacy of public health measures for COVID-19. This includes things like masks, hand sanitizer, and social distancing. Researchers used U.S. Marine recruits on Parris Island, South Carolina, to conduct the study. This was a great decision. After all, the authors could essentially ensure 100% compliance with the personal health measures in order to get the highest quality results from the study. Every Marine recruit quarantined for two weeks prior to moving to Parris Island to ensure that they weren’t infectious. The study started with a clean slate. 1,848 recruits participated in the study and adhered to the study’s public health measures:  All recruits wore double-layered cloth masks at all times indoors and outdoors.  They stayed at a distance of at least six feet.  No one was allowed to leave the campus.  No one had access to personal electronic devices or anything else that might be a surface for spreading transmission.  They practiced routine washing of hands.  Recruits cleaned their rooms daily (of course).  They sanitized their bathrooms with bleach wipes with each use.  They ate pre-plated meals in a dining hall that was cleaned with bleach after each platoon ate. I think we’ll agree that these are very strict measures taken in the hopes of stopping the spread of COVID-19. The high compliance and repeated cleanings after each use make this study unique. There were also 1,554 nonparticipants who did not take these measures. Over a 14-day period, all of the recruits were tested for COVID-19. We would expect the infection rates to be higher in those who did not participate in the strict personal health measures. But that’s not at all what happened. By day 14, 51 of the 1,848 participants had tested positive for COVID-19. Only 26 out of the 1,554 nonparticipants tested positive. In other words:  Those who wore masks, used bleach, and stayed strictly distanced tested positive at a rate of 2.8% within the first two weeks.  Those who didn’t and went about a normal life tested positive at a 1.7% rate over the same time period. I believe the journal agreed to publish the study because the authors drew no conclusions. They didn’t explore why the personal health measures were unsuccessful in stopping the spread of COVID-19 and produced worse results. They also didn’t explore why the infection rate was lower for those who didn’t participate. This is one of the very best studies that I’ve seen to date on COVID-19. And these insights should be used in public policy making for how we go about our lives. Regards, Alesa Anderson 1025 Westwood Drive Rexburg, Idaho 83442 208-709-0424 7F0968DBF4DD664CBC4B44BAC161D1DE@rexburg.org <017701d6bdd7$9f9a0da0$dece28e0$@gmail.com> Alesa Anderson SMTP alesaanderson@gmail.com SMTP alesaanderson@gmail.com Alesa Anderson Alesa Anderson Deborah Lovejoy Deborah Lovejoy Alesa Anderson Alesa Anderson alesaanderson@gmail.com alesaanderson@gmail.com Microsoft Outlook 15.0 Anonymous BT=1;II=01D6BDD3437CFC6DB218E39A42BB90BC5EB1A068940C;FIXUP=1.8905;Version=Version 15.0 (Build 847.0), Stage=H4 en CoR-EntMExSvr01.ci.rexburg.id.us https://10.10.0.3:443/cgi-mod/mark.cgi 1605725596 research on COVID-19 published last week in the New England Journal of Medicine mail-pj1-f53.google.com[209.85.216.53] by bsmtpd at rexburg.org No, SCORE=0.00 using global scores of TAG_LEVEL=3.5 QUARANTINE_LEVEL=1000.0 KILL_LEVEL=4.0 tests=HTML_MESSAGE Code version 3.2, rules version 3.2.3.85962 Rule breakdown below pts rule name description ---- ---------------------- -------------------------------------------------- 0.00 HTML_MESSAGE BODY: HTML included in message 0.00 1605725595-15095536b2afea30001-jsWnyn alesaanderson@gmail.com v=1; a=rsa-sha256; c=relaxed/relaxed; d=gmail.com; s=20161025; h=from:to:subject:date:message-id:mime-version:thread-index :content-language; bh=URJBbtNJa9IUG8/I0WrbDxaYS GWL5v8atNXxM63lu9Q=; b=An/GNMHYxU1wghorrukAZ+ytcPL7kWLLczCk70VJkPkgtE0+ui12oB3cSLHnnp90Gb XgsQF6+eO8XgCMEZple1bq7Axz08ovHHyQ5DnMlU4E0NkuR2/So7XAi4oXE32IrwQHun VtuiiGC6qhM1T3D98lPKHqAB1+HtnMwbrPFawY2Xz6VWOS05DPi0W1E2ZCl7jUmH/Vqt WNINmCaXxkInec4gybdttSEKKsDSkfzsTycTDW4FtXnzvW545w4p8jgyamaNSJ5Jmfpq gw7QOA0Ha53+KGn7G5pReFCn+g+gi8i7s/6GCoMADofT KFZuywyY0LYGn5Bd9Zb19Ujw +Alw== 209.85.216.53 1 v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20161025; h=x-gm-message-state:from:to:subject:date:message-id:mime-version :thread-index:content-language; bh=URJBbtNJa9IUG8/I0WrbDxaYSGWL5v8atNXxM63lu9Q=; b=MhddAN+kABmzc1LXPRG0Q/86K95ICunUuR1BQKPSYzWMOwh/bc2x+/8aKtdiFq2qCr 2Hl+nVYj3hustR2HGOS3VC52UoV2BHC0FOlDxeb/pDLMya4ERCV/fg/EP1 DatVjGweW0 7ibK9pg+6VdG+6bhSblMG+8phNJDvBOOd7cHXVSY4byTpB/F7cPe6rcB5Cdcwvpg9xue qNpW6DYsisLkgnUNW1lS6TGHabUqhzrwsiAL87+wy6jSHIj7KHgMbFIXpEF/2PHVgRJj bSyN1ikva879km4dr2iOAOZkks aDqb0gPHGo5mLB+Kt26tg4cBBpM93k6aaLWWvK/TnK EOXg== AOAM531BEMGFO+9lhz5X0lWNrnDFBW536FZEvAxTUvSso8O0m+gXMV5R LOIBc0GVvSirycJzNqVsfO1CHeXsi/0= by 2002:aa7:9ece:0:b029:18c:4931:a4e6 with SMTP id r14-20020aa79ece0000b029018c4931a4e6mr5787878pfq.56.1605723687348; Wed, 18 Nov 2020 10:21:27 -0800 (PST) Deborah.Lovejoy@rexburg.org 00000002/o=RexburgCityMail/ou=First Administrative Group/cn=Recipients/cn=deborahl Customer Services EX /o=RexburgCityMail/ou=First Administrative Group/cn=Recipients/cn=CustomerServices CustomerServices@rexburg.org Customer Services